Protego Biopharma
Protego Presents New Data at ISA 2026 that Advances Evidence for Light-Chain Stabilization with PROT-001 in AL Amyloidosis
- PROT-001, the company's investigational oral small molecule drug for AL amyloidosis, demonstrated an acceptable safety and tolerability profile in…
